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Original Article
Purpose: We explored whether the deep inspiration breath hold (DIBH) technique using Abches during left-sided breast irradiation 
was effective for minimizing the amount of radiation to the heart and lung compared to free breathing (FB).
Materials and Methods: Between February and July 2012, a total of 25 patients with left-sided breast cancer underwent 
two computed tomography scans each with the DIBH using Abches and using FB after breast-conserving surgery. The scans were 
retrospectively replanned using standardized criteria for the purpose of this study. The DIBH plans for each patient were compared 
with FB plans using dosimetric parameters.
Results: All patients were successfully treated with the DIBH technique using Abches. Significant differences were found between 
the DIBH and FB plans for mean heart dose (2.52 vs. 4.53 Gy), heart V30 (16.48 vs. 45.13 cm3), V20 (21.35 vs. 54.55 cm3), mean left 
anterior descending coronary artery (LAD) dose (16.01 vs. 26.26 Gy, all p < 0.001), and maximal dose to 0.2 cm3 of the LAD (41.65 
vs. 47.27 Gy, p = 0.017). The mean left lung dose (7.53 vs. 8.03 Gy, p = 0.073) and lung V20 (14.63% vs. 15.72%, p = 0.060) of DIBH 
using Abches were not different significantly compared with FB.
Conclusion: We report that the use of a DIBH technique using Abches in breathing adapted radiotherapy for left-sided breast 
cancer is easily feasible in daily practice and significantly reduces the radiation doses to the heart and LAD, therefore potentially 
reducing cardiac risk.
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Introduction
Postoperative radiotherapy for breast cancer patients has been 
shown to significantly reduce the risk of local recurrence as 
well as improving long-term survival [1,2]. However, many 
studies have demonstrated increased cardiac mortality and 
morbidity after breast radiotherapy [3-5]. Although many of 
the studies included in the this review involved old treatment 
techniques, which probably delivered a higher dose to the 
heart than seen in modern radiotherapy clinics, the issue of 
cardiac morbidity and mortality after breast cancer treatment 
is still relevant [6,7]. Therefore, dose-volume reduction of 
irradiation to the heart has become a common treatment goal 
in order to avoid increased risk of cardiovascular morbidity and 
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mortality. 
  A promising method for minimizing the volume of the heart 
included in the treatment field involves increasing the distance 
between the target and heart through deep inspiration. In 
the deep inspiration breath hold (DIBH) technique, the goal 
is to achieve the maximum separation between the target 
area and heart, with irradiation therefore taking place only 
at or near maximum inspiration. This allows high doses of 
radiation to be delivered to the chest wall and to the breast 
tissue while reducing the high dose area of the heart. The 
DIBH technique has been recommended to reduce radiation to 
the heart by displacing the breast and chest wall away from 
the heart during treatment [8-11]. Different methods, such 
as the use of real-time position management systems [12], 
active breathing control [13], and magnetic sensors [14] have 
been used to monitor or control respiratory motion. However, 
these methods have not been routinely implemented by many 
breast cancer treatment centers. The failure to adopt DIBH 
into routine practice is due to concern about increases in the 
required resources and workloads.
  We explored whether the DIBH technique using Abches during 
left-sided breast irradiation was effective for minimizing the 
amount of radiation to the heart and lung compared to free 
breathing (FB). This is the first study to evaluate the feasibility 
of DIBH using the commercially available Abches system and 
to incorporate this method into routine clinical practice. We 
also performed dosimetric evaluations to assess the extent of 
dose reduction to the heart, left anterior descending coronary 
artery (LAD), and ipsilateral lung.
Materials and Methods
1. Patient selection
Beginning in February 2012, we implemented the DIBH technique 
using Abches for selected patients undergoing adjuvant 
radiotherapy after breast-conserving surgery for left-sided 
invasive or in situ breast carcinoma at our institution. Patient 
selection criteria for DIBH irradiation were early stage (≤T2 and 
≤N1a stage) breast cancer for which whole breast irradiation 
(without regional nodal irradiation) was indicated. Between 
February and July 2012, the feasibility of 30-second DIBH 
was evaluated among 26 selected patients by a dedicated 
technician. Only 1 patient was excluded from use of the DIBH 
technique due to frequent cough. The remaining 25 patients 
underwent computed tomography (CT) simulation scans 
(SOMATOM sensation; Siemens, Erlangen, Germany) with both 
FB and DIBH without intravenous contrast. These scans were 
retrospectively replanned using standardized criteria for the 
purpose of this study. The median age of these patients was 29 
years (range, 23 to 76 years). 
2. Abches system
Abches is a respiration-monitoring device that was developed 
by Onishi et al. at the University of Yamanashi, Japan [15] (Fig. 
1). The main unit of the Abches system is composed primarily 
of plastic, with the use of metal kept to an absolute minimum. 
Fulcrum A and B are placed on the abdomen and breast of the 
patient, respectively. During respiration, pointer C of the device 
moves along with the fulcrum. This device therefore serves as 
an external device to monitor respiration. The Abches system 
is not used for gating irradiation but for facilitating precise 
irradiation of a target by assuring a stable breath hold. 
3. Respiratory control using the Abches system 
All patients were advised that the treatment was to be 
administered during respiratory standstill and were informed 
about the importance of reproducing the tumor position at the 
outpatient clinic by the treating physician. Next, each patient 
was trained how to hold her breath in the supine position with 
the left arm above the head in a customized arm support using 
a breast board to ensure that the sternum was in a horizontal 
position. Fig. 2 shows the procedure implemented for 
respiratory control using the Abches system. For all patients, 
the positions of fulcrum A and B were correctly reproduced 
every time using anatomical landmarks on the patient as 
Fig. 1. Abches system.
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indices, the contralateral breast and just below the xiphoid 
process, respectively. Patients were instructed to hold their 
breath at the end of inspiration and asked to practice breath 
holding by repeating the instructions “breathe in, out, and 
stop” with a mirror in front of the forehead (Fig. 2A). During 
each respiration session, the position of pointer C shifted 
with the fulcrum and stopped at some other fixed point. 
The red and blue marks indicated the ends of expiration and 
inspiration during regulatory respiration for each patient. The 
yellow mark indicated the deep inspiration breath hold, which 
is different for each patient. It was important that each patient 
maintained her breath hold well at the yellow mark (Fig. 2B–
D). The monitor was continuously observed during actual CT 
scanning and irradiation in the operating room. If the position 
pointer C varied considerably or if the patient could hold her 
breath for only a few seconds even after repeated training, the 
use of the Abches system was discontinued for that patient. 
4. Delineation of target volumes and organs at risk 
For consistency, the same physician performed all of the 
delineation procedures according to the Radiation Therapy 
Oncology Group guidelines using MIMvista ver. 5.4 (MIM 
Software, Cleveland, OH, USA), and the same CT threshold 
values, window levels and widths were used for all scans of 
all patients. The breast clinical target volume (CTV) included 
visible glandular breast tissue and the surgical cavity visualized 
on the CT scan, excluding 5 mm from the skin; contouring 
was assisted by a lead wire placed along the palpated breast 
tissue prior to the CT scan. Medially and laterally, the breast 
planning target volume (PTV) was defined by the angle of the 
tangential beams and extended from the midline to the mid-
axilla. Superiorly and inferiorly, the breast PTV was extended to 
include visible glandular breast tissue with a margin of 1.5 cm. 
If the boundary of the breast tissue could not be determined, 
the superior border was placed at the level of the suprasternal 
notch. The breast PTV was not adjusted to minimize the 
volume of the heart included within the tangential fields. The 
heart contour included the ventricles and atria, including the 
root of the aorta, the pulmonary artery and veins, and venae 
cavae. Since cardiac vessels run in the fatty tissue within the 
pericardium, they were included in the contours. The LAD 
was delineated from the root of the aorta to the apex of the 
heart with a standardized 5-mm diameter to account for 
uncertainties associated with cardiac motion and respiration. 
Intravenous contrast was not used for the CT scans. However, 
in most patients, the LAD could be visualized directly, and 
its position could also be identified according to its location 
overlying the interventricular septum [16]. The ipsilateral lung 
was delineated using the CT lung window.
  MIMvista ver. 5.4 (MIM Software) is an intensity-based 
Fig. 2. Procedure for respiratory 
control using the Abches system. 
(A) Patient position using Abches. 
(B) The red mark indicates the end 
of expiration during regulatory 
respiration.  (C) The blue mark 
indicates the end of inspiration 
during regulatory respiration. (D) 
The yellow mark indicates the deep 
inspiration breath hold.
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free-form deformable registration algorithm with essentially 
limitless degrees of freedom designed to expedite the 
delineation of target volumes and organs at risk. Rigid 
registration allows linear or uniform transformation of 
all voxels in the image set within six degrees of freedom 
(translations in three orthogonal directions and yaw, pitch, and 
roll rotations). It is of limited utility in the DIBH setting due to 
significant changes in anatomy. On the other hand, deformable 
registration algorithms compute the deformation maps of 
vector fields that can connect the voxels in FB CT images to 
DIBH CT images, a process that accounts for nonlinear and 
nonuniform relationships between the image sets. Thus, 
MIMvista is a useful tool for target volume delineation in 
breast cancer patients undergoing radiotherapy using the 
DIBH technique. Deformable registrations of images at our 
institution were performed with MIMvista. This algorithm was 
evaluated for clinical use by Piper [17].
5. Treatment planning and dosimetric evaluation
For each patient, both FB and DIBH CT scans were planned 
by a single dosimetrist to ensure plan uniformity. For all CT 
scans, computerized treatment planning was performed using 
Pinnacle ver. 9.4 (Philips, Andover, MA, USA). Two opposing 
6- or 10-MV tangential conformal fields with multileaf 
collimators were used. The prescription doses of all plans were 
50.4 Gy in 1.8 Gy per fraction for the whole breast.
  Comparisons of the following dosimetric values for FB and 
DIBH plans were performed using MIMvista: mean heart dose, 
the volume of the heart receiving 20 Gy and 30 Gy (heart V20 
and V30), mean LAD dose, the maximal dose to 0.2 cm3 of the 
LAD, the mean left lung dose and the volume of the left lung 
receiving 20 Gy (left lung V20). Because the LAD is a serial 
structure, the maximal dose to 0.2 cm3 of the LAD, which is 
approximately 1 cm in length using the standardized 5-mm 
diameter and may be more biologically relevant than the point 
maximal dose, was evaluated. Paired t-tests were performed 
using SPSS ver. 20.0 (SPSS Inc., Chicago, IL, USA) to compare 
dosimetric parameters between treatment techniques. A two-
tailed p < 0.05 was considered statistically significant.
Results
1. Patient compliance
After excluding only 1 patient from the DIBH technique 
because of frequent cough, the remaining 25 patients were 
successfully treated with the DIBH technique using Abches. 
The procedure was easily comprehended by patients. As 
noted earlier, because the patients were able to watch their 
own breathing by looking directly into a mirror, it was simple 
to educate the patients and the patients learned quickly. 
The mean monitor unit (MU) for two opposing 6- or 10-MV 
tangential plan was about 213 MU/min (range, 196 to 265 
MU/min) and the beam-on time for a dose rate of 400 MU/min 
was about 15 seconds. Thus, the breath hold was well accepted 
with a duration of about 15 seconds. All 25 patients were able 
to produce at least three consecutive breath holds without 
problems.
Table 1. Dosimetric comparison between FB and DIBH plans for all 25 patients
Variable FB plan DIBH plan p-valuea)
Heart 
   Mean dose (Gy)
   V30 (%)
   V30 absolute volume (cm3)
   V20 (%)
   V20 absolute volume (cm3)
LAD 
   Mean dose (Gy)
   Dmax 0.2 cm3 (Gy) 
Lung 
   Mean dose (Gy)
   V20 (%)
   V20 absolute volume (cm3)
 
4.53 (1.15–8.73)
6.31 (0.25–13.84)
45.13 (1.21–97.32)
7.64 (0.64–15.94)
54.55 (3.09–110.45)
 
26.26 (3.82–48.97)
47.27 (17.50–54.05)
 
8.04 (5.40–12.19)
15.72 (10.11–23.65)
279.73 (163.06–635.73)
 
2.52 (0.70–6.03)
2.80 (0.00–10.60)
16.48 (0.00–64.45)
3.16 (0.00–10.94)
21.35 (0.00–74.14)
 
16.01 (1.84–31.22)
41.65 (5.43–53.21)
 
7.53 (5.07–10.43)
14.63 (10.30–21.14)
182.76 (76.43–342.84)
 
<0.001
<0.001
<0.001
<0.001
<0.001
 
<0.001
0.017
 
0.073
0.060 
0.059
Values are presented as mean (range).
FB, free breathing; DIBH, deep inspiration breath hold; LAD, left anterior descending coronary artery.
a)Paired t-test.
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2. Dosimetric comparison between FB and DIBH plans
As shown in Table 1, significant differences were found between 
the DIBH and FB plans for the mean heart dose (2.52 vs. 4.53 
Gy), heart V30 (16.48 vs. 45.13 cm3), V20 (21.35 vs. 54.55 cm3), 
mean LAD dose (16.01 vs. 26.26 Gy, all p < 0.001), and maximal 
dose to 0.2 cm3 of the LAD (41.65 vs. 47.27 Gy, p = 0.017). In 
Fig. 3, beams-eye views are shown for the medial tangential 
fields of left-sided breast cancer patients for both FB and DIBH. 
Cardiac volume within the radiation field was minimized as 
much as possible, primarily by conforming the posterior borders 
of the tangential fields to the CTV using multileaf collimators. 
The use of DIBH allowed the left-sided breast and heart to 
be separated during radiation treatment, thus excluding 
substantial heart volumes from the high dose area. This is 
demonstrated by the calculated dose volume histogram (Fig. 
4). There were significantly lower doses delivered to the heart 
and LAD with the DIBH plan compared to the FB plan. Although 
lung inflation during DIBH increased the absolute lung volume 
within the field on beams-eye view (Fig. 3), the mean left lung 
dose (7.53 vs. 8.03 Gy, p = 0.073) and lung V20 (14.63% vs. 
15.72%, p = 0.060) were reduced with DIBH compared to the 
FB plan (Table 1), although the difference was not significant.
3. Workload requirements and patient and staff acceptance
The implementation of the DIBH technique required minimal 
additional resources and only a moderate increase in workload. 
Fig. 3. Beams-eye views of the 
medial tangential fields for free 
breathing (A) and deep inspiration 
breath hold (B) plans. Heart outline 
in pink, left anterior descending 
coronary artery in red, and surgical 
cavity in sky blue.
Fig. 4. Dose volume histograms comparing free breathing (A) and deep inspiration breath hold (B) plans for the same patient. Whole 
breast line in green, left anterior descending coronary artery in red, heart in pink, and ipsilateral lung in blue.
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We assessed the overall treatment time for each patient. The 
mean durations of FB and DIBH were about 5 minutes 10 
seconds and 10 minutes 30 seconds, respectively. All planning 
staff became familiar with the DIBH planning and Abches 
education processes. Staff responsible for operating breast 
cancer treatment machines became proficient with patient 
setup and treatment delivery using Abches in about 6 weeks.
Discussion and Conclusion
Delivering treatment to the left breast using the DIBH 
technique has been shown to reduce both the irradiated heart 
volume and dose to the heart. Early studies indicated that 
DIBH could reduce the volume of the heart within tangential 
fields. Remouchamps et al. [8] reported a mean absolute 
reduction in heart V30 of 3.6% in a preliminary study including 
five patients. Korreman et al. [18] reported a reduction in 
the median heart volume receiving more than 50% of the 
prescription dose from 19.2% to 1.9% and a reduction in 
the median volume of the LAD receiving the same dose from 
88.9% to 3.6% in a sample of nine patients. In a subsequent 
publication, the same group used the relative seriality model 
to calculate the expected reduction in cardiac mortality from 
the use of DIBH in 16 cases. The cardiac mortality probabilities 
for FB and DIBH were 4.8% and 0.1% [12]. 
  More recent reports support these findings. At Princess 
Margaret Hospital, Toronto, Canada, 20 patients were planned 
for both FB and DIBH treatments. Statistically significant 
reductions in the volume of the heart receiving more than 
50% of the prescription dose, mean heart dose, mean LAD 
dose, and the maximum dose to 0.2 cm3 of the LAD were noted 
after applying the DIBH technique [11]. In a similar study of 19 
unselected patients from the Netherlands Cancer Institute the 
maximum and mean doses and the V30 for the heart, the left 
ventricle and the LAD were all significantly reduced by DIBH 
[10]. Several reports have documented the tolerability and 
interfraction reproducibility of the DIBH technique [13,19,20].
  Our data are consistent with those of other published reports 
demonstrating significant reductions in the doses to the heart 
and LAD with DIBH technique using Abches. However, several 
factors may limit comparisons between studies. The reported 
heart doses may be influenced by variability in the method 
used to contour the heart between studies. We employed non-
contrast CT scans to outline the atria and ventricles. Previous 
studies excluded the epicardial fat and pericardium, the 
roots of the great vessels and/or the venae cavae, and were 
performed with or without the use of intravenous contrast. 
Contouring the coronary arteries is particularly difficult, as 
they are often poorly visualized due to non-contrast CT scans 
and often seem noncontiguous throughout the data set 
due to cardiac and respiratory motion. To account for these 
uncertainties, we used a standardized contouring protocol 
[16]. We attempted to maintain consistency of volume 
measurements by employing the same radiation oncologist to 
perform all contouring. Even so, some minor variations in all 
contours may have occurred due to variation in the anatomy 
of the heart and lung between FB and DIBH scans. 
  Although the absolute left lung volume appeared to have 
increased with DIBH, proportionately less of the left lung 
was irradiated. While lung volume may increase with deep 
inspiration, the lung density may decrease, resulting in 
irradiation of a reduced fraction of normal lung mass [21]. 
In our study, the mean left lung dose (7.53 vs. 8.03 Gy, p = 
0.073) and percentage of the left lung (14.63% vs. 15.7%, 
p = 0.060) receiving 20 Gy were both smaller with DIBH 
(borderline significance). Therefore, the risk of radiation-induced 
pneumonitis is unlikely to increase using the DIBH technique.
  Implementing the DIBH technique using Abches for all 
patients receiving left-sided breast radiotherapy was neither 
desirable nor feasible, because the benefits were questionable 
for most patients with minimal or no heart included within the 
radiation field. Therefore, it is important to establish criteria to 
select patients with unfavorable cardiac anatomy, who would 
benefit most from using Abches. Our results demonstrate 
that DIBH technique using Abches resulted in statistically 
significant reductions in the mean heart dose, heart V20, heart 
V30, mean LAD dose, and maximal dose to 0.2 cm3 of the LAD. 
These parameters may be of assistance in identifying patients 
with unfavorable cardiac anatomy who would most benefit 
from reductions in cardiac dose during radiotherapy to the left 
breast. Further research is needed to determine which patients 
are likely to derive the most benefit from this technique before 
DIBH CT scans are performed.
  It has been demonstrated in several studies that breathing 
adaptation techniques can be used to reduce the irradiated 
heart and lung volumes, primarily by utilizing lung inflation 
which dilutes the amount of lung tissue in the radiation 
fields and spatially separates the heart from target. An active 
breathing control device has been used to freeze the lung 
volume at 75% of maximum inspiration capacity, providing 
significant lung and heart dose reductions [22]. The device 
consists of a digital spirometer to record the patients’ real-
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time breathing trace and a balloon valve that is triggered 
to automatically inflate when the patient inspire to their 
preset DIBH level. This allows for a predictable, consistent 
level of chest wall expansion with each DIBH. Another one 
of breathing adaptation techniques is the Real-time Position 
Management (RPM) system (Varian Medical Systems, Palo 
Alto, CA, USA). The device permits breathing-synchronized CT 
scanning and radiotherapy during certain time intervals on the 
linear accelerator [18]. The position and chest wall excursion 
are assessed individually for each breath-hold mode, and the 
patient is then instructed to repeat each mode to improve 
reproducibility. We think that Abches would probably be less 
precise than other breathing adaptation techniques in terms of 
consistent level of chest wall expansion and reproducibility of 
breath-hold level.
  However, because the patient can monitor her own breathing 
and breath holds with durations of about 15 seconds were well 
accepted, the breathing procedure was easily comprehensible 
to the patients and there was good compliance using Abches. 
In addition, the main unit of the Abches system is composed 
primarily of plastic and is therefore quite light. Thus, it is 
easy to perform patient setup in the radiation treatment 
room without affecting dose calculation using the radiation 
treatment planning system (Pinnacle ver. 9.4, Philips). All 
planning staff easily became familiar with the DIBH planning 
and Abches education processes. The staff who operated 
breast cancer treatment machines became proficient with 
patient setup and treatment delivery using Abches after about 
6 weeks. The additional workload per patient treated with 
DIBH using Abches was modest, and the use of MIMvista 
dramatically reduced the breast radiation treatment planning 
time, allowing rapid delineation and dose-volume assessments 
of organs at risk in real-time using a FB plan. This procedure 
can be implemented for routine use in busy clinics.
  In conclusions, we report that the application of the DIBH 
technique using Abches in breathing adapted radiotherapy for 
left-sided breast cancer is easily feasible in daily practice and 
significantly reduces the doses to the heart and LAD, therefore 
potentially reducing the cardiac risk. Based on the results of 
this study, at our institution we now treat left-sided breast 
cancer patients with Abches.
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